Condition
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Leukemia, Lymphoblastic, Acute, Philadelphia-Positive clinical trials that are recruiting, at sites in 14 countries (most in Australia (2), South Korea (2), China (2)). By phase: Phase 1/2 (1), Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 14Countries
Newest Leukemia, Lymphoblastic, Acute, Philadelphia-Positive clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Asciminib in children and young adults with relapsed or refractory Ph+ or ABL-class Ph-like ALL | Phase 1/2 | Sydney, New South Wales and 3 other locations | Recruiting | Feb 4, 2026 |
| Evaluating Olverembatinib for Newly Diagnosed Ph+ ALL | Phase 3 | Birmingham, Alabama and 89 other locations | Recruiting | Sep 22, 2023 |
| Olverembatinib plus APG-2575 for children with relapsed or refractory Philadelphia-positive ALL | Phase 1 | Hefei, Anhui and 3 other locations | Recruiting | Aug 10, 2022 |
All recruiting trials (3)
-
Asciminib in children and young adults with relapsed or refractory Ph+ or ABL-class Ph-like ALL
This study tests asciminib in kids and young adults with relapsed or refractory Philadelphia-positive or ABL-class Ph-like ALL to see if it is safe and helps treat the leukemia.
-
Evaluating Olverembatinib for Newly Diagnosed Ph+ ALL
This study is testing if a new drug called Olverembatinib, used with chemotherapy, can help people with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia do better than the standard treatment with Imatinib and chemotherapy.
-
Olverembatinib plus APG-2575 for children with relapsed or refractory Philadelphia-positive ALL
This study tests whether a combination of olverembatinib and APG-2575, with dexamethasone, is safe and potentially effective in children with relapsed or refractory Ph+ ALL who have already tried other TKIs.
Related topics
Quick answers
How many Leukemia, Lymphoblastic, Acute, Philadelphia-Positive clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in Australia (2 trials), South Korea (2 trials), China (2 trials), Israel (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.